Pfizer Inc. (NYSE:PFE) shares traded 0.62% higher at $30.84 on Wall Street last session.
In accordance with the data, 26 analysts cover Pfizer Inc. (NYSE:PFE). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $75.00 and a low of $32.00, we find $38.50. Given the previous closing price of $30.65, this indicates a potential upside of 25.61 percent. PFE stock price is now -9.74% away from the 50-day moving average and -19.99% away from the 200-day moving average. The market capitalization of the company currently stands at $174.12B.
It has been rated a hold by 14 analysts and a buy by 11. Brokers who have rated the stock have averaged $40.41 as their price target over the next twelve months.
In other news, Gottlieb Scott, Director bought 1,000 shares of the company’s stock on May 08. The stock was bought for $38,580 at an average price of $38.58. Upon completion of the transaction, the Director now directly owns 6,000 shares in the company, valued at $0.19 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 05, Director Gottlieb Scott bought 1,000 shares of the business’s stock. A total of $38,425 was incurred on buying the stock at an average price of $38.42. This leaves the insider owning 5,000 shares of the company worth $0.15 million. Insiders disposed of 545,539 shares of company stock worth roughly $16.82 million over the past 1 year. A total of 0.04% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in PFE stock. A new stake in Pfizer Inc. shares was purchased by AUSTRALIANSUPER PTY LTD during the first quarter worth $83,238,000. MN SERVICES VERMOGENSBEHEER B.V. invested $83,166,000 in shares of PFE during the first quarter. In the first quarter, ARMISTICE CAPITAL, LLC acquired a new stake in Pfizer Inc. valued at approximately $64,641,000. UNISUPER MANAGEMENT PTY LTD acquired a new stake in PFE for approximately $47,887,000. AVIDITY PARTNERS MANAGEMENT LP purchased a new stake in PFE valued at around $34,463,000 in the second quarter. In total, there are 3,882 active investors with 70.79% ownership of the company’s stock.
Pfizer Inc. (NYSE: PFE) opened at $30.77 on Monday. During the past 12 months, Pfizer Inc. has had a low of $30.48 and a high of $54.93. As of last week, the company has a debt-to-equity ratio of 0.66, a current ratio of 2.12, and a quick ratio of 1.82. The fifty day moving average price for PFE is $34.06 and a two-hundred day moving average price translates $38.45 for the stock.
The latest earnings results from Pfizer Inc. (NYSE: PFE) was released for Jul, 2023. According to the Drug Manufacturers – General Company, earnings per share came in at $0.67, beating analysts’ expectations of $0.57 by 0.1. This compares to $0.01 EPS in the same period last year. The net profit margin was 27.57% and return on equity was 23.08% for PFE. The company reported revenue of $12.73 billion for the quarter, compared to $27.74 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -54.1 percent. For the current quarter, analysts expect PFE to generate $12.72B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 09/05/2023. Investors who held shares on 07/28/2023 were paid a $0.41 dividend. On an annualized basis, this represents a $1.56 dividend and a 5.07% percent yield. There was an ex-dividend date of 07/27/2023 for this dividend. In terms of dividend payout ratio, PFE is presently at 29.43%.
